ORMP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now for an impatient investor. ORMP shows a longer-term bullish moving-average structure, but near-term momentum is weakening (MACD histogram negative and expanding). With no Intellectia signals, no fresh news catalysts, and extremely high implied volatility (options market pricing big moves), the risk/reward for buying immediately is not attractive. If you must act now, holding (not adding) is the better call until price can reclaim and hold above the 3.51 pivot/near-term resistance.
Pre-market ~3.44 (+0.58%) with the S&P 500 down ~0.4%. Trend is mixed: (1) Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), implying the broader structure is still constructive. (2) Momentum is deteriorating: MACD histogram -0.0242 and negatively expanding, which often precedes/continues short-term pullbacks. (3) RSI_6 at ~47 is neutral—no oversold bounce signal. Key levels: Support S1 3.354 then S2 3.259; Resistance/pivot area 3.507 (pivot) then R1 3.659 and R2 3.754. Immediate read: price is near support (3.35) but below the key pivot (3.51), so upside confirmation is not present yet.
Technical structure still leans bullish via moving averages (SMA stack).
Options market sentiment is strongly call-skewed (calls dominate OI and volume).
Pattern-based projection suggests mild upside odds (model: ~60% chance of small gains over 1D/1W/1M).
No Intellectia signals today: AI Stock Picker shows no buy; SwingMax shows no recent entry—no high-conviction timing trigger.
MACD momentum is bearish/weakening despite bullish MAs, raising near-term downside/whipsaw risk.
No news in the last week—no clear event-driven catalyst to justify the very high options IV.
Extremely high IV implies the market is pricing big moves; buying stock now risks paying for uncertainty without confirmation above 3.51.
Latest reported quarter: 2025/Q3. Revenue is effectively 0 (no growth base). Net income is reported at ~$48.4M but down sharply YoY (-346.67%), and EPS 1.13 also down sharply YoY (-335.42%). Gross margin listed at ~0.65. Overall: profitability metrics are volatile and the revenue line shows no operating growth signal in this snapshot, which weakens the fundamental momentum case.
No analyst rating or price target change data was provided, so a recent trend summary cannot be verified here. With the available data, Wall Street pros/cons can’t be corroborated; sentiment must be inferred primarily from technicals and options (call-skewed but high-IV uncertainty). Politician/congress activity: no recent congress trading data available; hedge funds and insiders are described as neutral with no significant recent trends.
